Skip to content

Effect of subcutaneous sterile water injection on back pain of Women with Active Phase of Labor

Survey of Back Pain Reduction With and Without Subcutaneous Sterile Water Injection In Women With Active Phase of Labor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181023041427N1
Enrollment
90
Registered
2018-12-19
Start date
2018-12-22
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Active labor phase.

Interventions

Intervention 1: Intervention group: Injection of 0.5 ml sterile water subcutaneously in 4 site of sacrum. Intervention 2: Control group : Insertion of needle without injection of certain material in

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Nulliparous women with an Iranian nationality Women 18-35 years old Term pregnancy (38-42 weeks) Start of uterine contractions and active phase of labor pain in the lower back ?Singleton live fetus with a weight of over 2500 grams The embryo with anterior occiputa position the absence of sedative drugs, systemic and topical analgesic drugs use up to ninety minutes after intervention

Exclusion criteria

Exclusion criteria: No Informed consent Any systemic disease associated with pregnancy including diabetes, hypertension, heart diseases, etc., History of narcotic and alcohol consumption, history of psychiatric illness and depression Trauma created during childbirth (when using labor tools such as forceps or vacuum, a large perineal rupture, postpartum hemorrhage, etc.) Any need for emergency intervention for maternal and fetal reasons such as placenta abruption Maternal hospitalization during pregnancy Emergency cesarean delivery for any reason during labor

Design outcomes

Primary

MeasureTime frame
Labor pain. Timepoint: 10, 45 and 90 Minutes after injection. Method of measurement: Visual analog scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzane khajehnazari

Kerman University of Medical Sciences

F.khajehnazari@gmIl.com+98 34 4200 8281

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026